Prime Minister Justin Trudeau said Monday Canada will get up to 250,000 doses of the vaccine developed by American drugmaker Pfizer and Germany's BioNTech before the end of December.
The vaccine is expected be approved by Health Canada as soon as Thursday.
Trudeau had come under criticism from opposition parties for saying Canadians won't be among the first to get a vaccine against COVID-19 because the first doses will likely go to citizens of the countries they are made in. Canada doesn't have mass vaccine-production facilities.
Trudeau said Canada has contracts with six other vaccine makers as well.
Seniors and workers in long-term care homes are among those expected to get the vaccine first.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU